Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tryptase gamma 1 (TPSG1) is a membrane-associated serine protease encoded by the human TPSG1 gene, located on chromosome 16p13.3[1][3][4]. It is a member of the tryptase family (peptidase family S1), with a distinctive C-terminal hydrophobic domain for membrane anchoring, unlike other secretory tryptases[1][3]. TPSG1 is mainly associated with mast cells and, to a lesser extent, basophils, and is implicated in proteolytic cleavage of substrates during immune and allergic responses[1][3][4]. Tryptase gamma 1 is active as a heparin-stabilized tetramer and is resilient to most endogenous inhibitors[3][4]. It has been linked to the pathogenesis of asthma, allergic inflammation, and related disorders[1][4][6]. Recent evidence suggests a possible role in tumor cell migration and invasion, such as in breast cancer[6].
Serine protease inhibition (theoretical, as tryptase inhibitors have been explored for related tryptases)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tryptase gamma 1 (TPSG1).